Ghisallo Capital Management LLC lessened its stake in shares of Waystar Holding Corp. (NASDAQ:WAY – Free Report) by 28.6% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 500,000 shares of the company’s stock after selling 200,000 shares during the quarter. Ghisallo Capital Management LLC’s holdings in Waystar were worth $18,960,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Salomon & Ludwin LLC acquired a new position in Waystar in the 3rd quarter worth about $25,000. ANTIPODES PARTNERS Ltd raised its holdings in Waystar by 120.1% in the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock valued at $31,000 after buying an additional 449 shares during the last quarter. First Horizon Corp acquired a new stake in Waystar during the 3rd quarter worth approximately $38,000. EverSource Wealth Advisors LLC increased its position in Waystar by 3,219.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock valued at $57,000 after acquiring an additional 1,352 shares during the period. Finally, CWM LLC raised its stake in shares of Waystar by 515.8% during the third quarter. CWM LLC now owns 2,100 shares of the company’s stock valued at $80,000 after acquiring an additional 1,759 shares during the last quarter.
Waystar Stock Performance
Shares of Waystar stock opened at $24.16 on Friday. Waystar Holding Corp. has a 52 week low of $21.13 and a 52 week high of $42.55. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.38. The business has a 50 day moving average price of $26.97 and a 200-day moving average price of $33.00. The company has a market cap of $4.63 billion, a PE ratio of 39.61, a price-to-earnings-growth ratio of 0.96 and a beta of 0.80.
Analysts Set New Price Targets
A number of analysts recently weighed in on the company. The Goldman Sachs Group decreased their price objective on Waystar from $44.00 to $38.00 and set a “buy” rating for the company in a report on Wednesday, February 18th. Wall Street Zen cut Waystar from a “buy” rating to a “hold” rating in a report on Saturday, February 21st. Needham & Company LLC lowered their price target on shares of Waystar from $46.00 to $33.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. Truist Financial reduced their price objective on shares of Waystar from $51.00 to $38.00 and set a “buy” rating on the stock in a research note on Wednesday, February 18th. Finally, Barclays lowered their target price on Waystar from $42.00 to $36.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. Three analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Waystar has an average rating of “Buy” and an average target price of $37.06.
Insiders Place Their Bets
In other news, insider Eric L. (Ric) Sinclair III sold 40,225 shares of the stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $30.08, for a total transaction of $1,209,968.00. Following the completion of the transaction, the insider directly owned 474,826 shares of the company’s stock, valued at $14,282,766.08. This represents a 7.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 4.10% of the stock is currently owned by insiders.
Waystar Profile
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Read More
- Five stocks we like better than Waystar
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- Iran isn’t the real war
- This coin has everything going for it
- Only 500 people today…
Want to see what other hedge funds are holding WAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waystar Holding Corp. (NASDAQ:WAY – Free Report).
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
